takeda pharmaceutical co

CiRA & Takeda Announce Joint iPS Cell Research

Takeda, Japan's largest pharmaceutical company, will provide US$166 million of funding for iPS research over the next ten years.

AstraZeneca Expands Presence in Asia With Deals in China and Japan

AstraZeneca has entered a strategic alliance with WuXi AppTech and acquired Takeda's respiratory business.

Teva & Takeda Enter Joint Venture For Generics In Japan

Asia's largest pharmaceutical company has entered a partnership with Teva to provide generic drugs to Japan.

Takeda Joins WIPO Re:Search To Accelerate R&D

Through the WIPO Re:Search consortium, Japanese pharmaceutical Takeda plans to share intellectual property assets to facilitate R&D in neglected tropical diseases.

Single-Dose Malaria Drug Reaches Human Trials

A long-lasting single-dose malaria drug in phase II clinical trials provides hope for malaria-infected patients.

Removing Early Barriers To Drugs For Neglected Diseases

DNDi has formed a consortium with four pharmaceutical companies to hasten the development of drugs for leishmaniasis and Chagas disease.

Takeda To Distribute KAKETSUKEN’s Influenza Vaccine

To meet the growing demand for seasonal flu vaccines, Takeda has added KAKETSUKEN to its list of suppliers.

Japan’s NCC & Takeda Enter Research Partnership

The collaboration between the National Cancer Center and Takeda is part of a wider academic-industrial effort to develop new medicines.

CiRA & Takeda Undertake US$267 Million iPS Collaboration

The ten-year research collaboration to be hosted at Takeda's Shonan Research Center will focus on developing clinical applications for iPS cells.